About BIO
BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.
We serve the needs of small-to-medium size companies, most of whom do not yet have major products approved and on the market. Whether advocating for pro-innovation tax policies to encouraging an economic and policy environment to foster biotech investment, we focus on critical issues affecting smaller companies and build programs to enhance their development.
We promote biomedical innovation by developing and advocating for public policies that represent the best interests of members focused on human health. We break-down the barriers that impede American innovation by reducing bureaucratic hurdles to lifesaving technologies. Among the priority issues are matters affecting the healthcare-related regulatory and reimbursement climate, pandemic and biodefense preparedness, publicly funded scientific research, and personalized medicine.
BIO is committed to supporting biobased breakthroughs at all stages of development and technology developers of all types and sizes. From public education campaigns to pushing for regulations that keep pace with innovation, we take on the policy challenges and activism that can threaten innovations in food and on the farm, biobased manufacturing, and green energy breakthroughs.
Good Day BIO, the only daily newsletter at the intersection of biotech, politics, and policy. Subscribe to get it delivered to your inbox every weekday at 10 AM ET—and stay ahead of the news of the day.
Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.
.png){kind=logo}
